Attached files

file filename
EX-99.1 - EX-99.1 - Quorum Health Corpqhc-ex991_6.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (date of earliest event reported): May 15, 2017

 

QUORUM HEALTH CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-37550

 

47-4725208

(State or other jurisdiction

of incorporation)

 

(Commission
file number)

 

(IRS Employer

Identification No.)

 

 

 

 

 

1573 Mallory Lane

Brentwood, Tennessee 37027

 

(Address of principal executive offices)

 

Registrant’s Telephone Number, Including Area Code: (615) 221-1400

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 

 

 

 


 

 

The information contained in this Current Report on Form 8-K (including the exhibits hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

Item 2.02Results of Operations and Financial Condition

On May 15, 2017, Quorum Health Corporation (the “Company”) announced operating results for the three months ended March 31, 2017.  A copy of the press release making this announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 2.02.

Item 7.01Regulation FD Disclosure

The press release referred to in Item 2.02 above updates the Company’s 2017 annual earnings guidance, which was most recently updated by the Company on March 29, 2017.  The 2017 guidance is based on the Company’s historical operating performance, current trends and other assumptions the Company believes are reasonable at this time as set forth in the press release. A copy of the press release making this announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 7.01.

Item 9.01Financial Statements and Exhibits

(d)Exhibits

The information required by this Item is set forth in the Index to Exhibits that follows the signature page of this Current Report on Form 8-K.

1

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

QUORUM HEALTH CORPORATION

(registrant)

 

By:

 

/s/ Michael J. Culotta

 

 

Michael J. Culotta

 

 

Executive Vice President

 

 

And Chief Financial Officer

 

 

(principal financial officer

and principal accounting officer)

Date: May 15, 2017

 

2

 


 

Index to Exhibits

 

No.

 

Description

 

 

 

99.1

 

Quorum Health Corporation Press Release, dated May 15, 2017

 

3

 


 

 

1